This week we highlight why people may be skipping their second COVID-19 dose, challenges of AI in patient diagnosis, the evolution of the regulatory environment for biopharma companies and more. … READ MORE >
life sciences
5 things to know in life sciences: Week of April 19
This week our senior analysts highlight FDA approval decisions, venture funds focused on life sciences, newly approved remote patient monitoring devices and more. … READ MORE >
5 things to know in life sciences: Week of April 12
This week we highlight the backstory of challenges that have haunted the AstraZeneca vaccine efforts, machine learning that improves drug delivery, genetically modified mosquitoes and more. … READ MORE >
5 things to know in life sciences: Week of April 5
This week we highlight vaccine mandate considerations, the lack of diversity on the boards of life sciences companies, a promising new class of drugs and more. … READ MORE >
5 things to know in life sciences: Week of March 29
From biopharma merger scrutiny to AI-powered biology research, we highlight what’s happening in the life sciences industry this week. … READ MORE >
CHART OF THE DAY: FTC challenges biopharma merger as antitrust scrutiny grows
Less than two weeks after the Federal Trade Commission announced it would be taking a more stringent look at mergers in the biopharmaceutical industry, the proposed Illumina and Grail merger became only the second vertical merger in 40 years to be legally challenged by the agency. … READ MORE >
5 things to know in life sciences: Week of March 15
This week we highlight possible heightened scrutiny related to pharma mergers, top drugs losing their exclusivity this year, artificial intelligence-powered hearing aids and more. … READ MORE >
An evolution of the economy: Living, and adapting, with COVID-19
What should middle market businesses consider in terms of a COVID-19 endemic future? Evaluating existing business models, updating policies and making investments in technology and digital infrastructure are just a few components. … READ MORE >
Understanding the rapid spread of COVID-19 variants
The emergence of COVID-19 variants is why the efficient and equitable distribution of vaccines across all nations is critical. … READ MORE >
5 things to know in life sciences: Week of March 8
This week we examine COVID-19 variants, heightened scrutiny on accelerated approval phase 4 confirmatory trials, gaps in the understanding of racial and ethnic representation in vaccine trials, tiny cancer-fighting robots and more. … READ MORE >